about
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer.Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic strokeLeukoaraiosis is associated with pneumonia after acute ischemic stroke.Nocturnal Desaturation in the Stroke Unit Is Associated With Wake-Up Ischemic Stroke.The presence and severity of cerebral small vessel disease increases the frequency of stroke in a cohort of patients with large artery occlusive disease.Clinical relevance of abnormal neuroimaging findings and long-term risk of stroke recurrence.Distal hyperintense vessel sign is associated with neurological deterioration in acute ischaemic stroke.D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.Severe White Matter Hyperintensity Is Associated with Early Neurological Deterioration in Patients with Isolated Pontine Infarction.Temporal changes in the neutrophil to lymphocyte ratio and the neurological progression in cryptogenic stroke with active cancer.Remote Management of Poststroke Patients With a Smartphone-Based Management System Integrated in Clinical Care: Prospective, Nonrandomized, Interventional StudyCystatin C is a useful predictor of early neurological deterioration following ischaemic stroke in elderly patients with normal renal functionLeft ventricular ejection fraction is associated with small vessel disease in ischaemic stroke patientsClopidogrel may decrease the risk of post-stroke infection after ischaemic strokeKidney Dysfunction Impact on White Matter Hyperintensity Volume in Neurologically Healthy AdultsNeutrophil-to-lymphocyte ratio predicts early worsening in stroke due to large vessel diseaseFavorable impact of non-alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy populationPooled cohort risk equation and subclinical cerebrovascular diseasesHigh triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: a cross-sectional study
P50
Q33808916-0B9DBE38-165D-4EFC-94C2-F4FDC2AA86AAQ36304201-FD57A451-4304-4AC7-82C5-E8DFF4CB0CFAQ36311206-D9F268C4-6148-4592-A352-5D777C57D2EDQ39737896-EA7C00B6-DA3D-4A1F-BA26-49932E6A7026Q42708434-063D0BC1-991D-40FA-987E-FD3998AB260CQ48142983-D8C658ED-7A5A-4DAF-A96D-7A5B0CC39BF1Q48297924-FD53D60C-D46A-4A5F-954B-F716CF8CC7A5Q48467920-3E0141FE-C62B-4536-8547-5CCD594CFAFAQ48475789-1BDA695F-FDCC-4A9E-A3DE-28878735E50FQ55002631-DBCFAFD5-1785-48B1-9BD8-9E24F23D14F0Q90034580-11912184-BFBF-4B22-8223-844894E4C352Q90108422-6BC923F4-FA44-4C61-ABEE-C6E4ED5BC0FEQ90628619-DFE1BFD0-3BE2-41E8-B781-610FE300BF77Q91247834-D2896E6B-3EE9-4F2B-9DD5-A31A7F8390C1Q92734016-B3A6ED57-0A44-43C8-99BC-7F91E6279E6DQ92867269-154F0726-B666-4829-95E8-0BEBB08D70B4Q92985153-00066E02-7EBA-4136-95F8-731AFB669985Q93026604-EB674214-BC96-4593-943A-D4C309690AE4Q94585735-10BA7B6E-FB12-4789-B6CD-EC7B16D24921
P50
description
researcher ORCID ID = 0000-0001-7514-6264
@en
wetenschapper
@nl
name
Ki-Woong Nam
@ast
Ki-Woong Nam
@en
Ki-Woong Nam
@es
Ki-Woong Nam
@nl
type
label
Ki-Woong Nam
@ast
Ki-Woong Nam
@en
Ki-Woong Nam
@es
Ki-Woong Nam
@nl
prefLabel
Ki-Woong Nam
@ast
Ki-Woong Nam
@en
Ki-Woong Nam
@es
Ki-Woong Nam
@nl
P106
P31
P496
0000-0001-7514-6264